Joeky Senders

64 Chapter 3 18. Lyman GH, Bohlke K, Falanga A, American Society of Clinical O. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract. 2015;11(3):e442-444. 19. Streiff MB. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Cancer-Associated Venous Thromboembolic Disease. Version 1.2014. In: National Comprehensive Cancer Network; 2014. 20. Zwicker JI, Karp Leaf R, Carrier M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Journal of thrombosis and haemostasis : JTH. 2016;14(9):1736- 1740. 21. Zwicker JIKL, R.; Carrier, M. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation. Journal of thrombosis and haemostasis : JTH. 2016;14(9):1736- 1740. 22. Nghiemphu PLG, R. M.; Pope, W. B.; Lai, A.; Cloughesy, T. F. Safety of anticoagulation use and bevacizumab in patients with glioma. Neuro-oncology. 2008;10(3):355-360. 23. Nabi SK, P.; Bozorgnia, F.; Arshad, A.; Mikkelsen, T.; Donthireddy, V. Predictors of Venous Thromboembolism in Patients with Glioblastoma. Pathology oncology research : POR. 2016;22(2):311-316. 24. Mantia CU, E. J.; Puligandla, M.; Weber, G. M.; Neuberg, D.; Zwicker, J. I. Predicting the higher rate of intracranial hemorrhage in glioma patients receiving therapeutic enoxaparin. Blood. 2017. 25. Al Megren MDW, C.; Al Qahtani, M.; Le Gal, G.; Carrier, M. Management of venous thromboembolism in patients with glioma. Thrombosis research. 2017;156:105-108. 26. Lieber BA, Appelboom G, Taylor BE, Malone H, Agarwal N, Connolly ES, Jr. Assessment of the "July Effect": outcomes after early resident transition in adult neurosurgery. Journal of neurosurgery. 2015:1-9. 27. McGirt MJ, Godil SS, Asher AL, Parker SL, Devin CJ. Quality analysis of anterior cervical discectomy and fusion in the outpatient versus inpatient setting: analysis of 7288 patients from the NSQIP database. Neurosurgical focus. 2015;39(6):E9. 28. Lieber BA, Appelboom G, Taylor BE, et al. Preoperative chemotherapy and corticosteroids: independent predictors of cranial surgical-site infections. Journal of neurosurgery. 2015:1-9. 29. Lim S, Parsa AT, Kim BD, Rosenow JM, Kim JY. Impact of resident involvement in neurosurgery: an analysis of 8748 patients from the 2011 American College of Surgeons National Surgical Quality Improvement Program database. Journal of neurosurgery. 2015;122(4):962-970. 30. McCutcheon BA, Ciacci JD, Marcus LP, et al. Thirty-Day Perioperative Outcomes in Spinal Fusion by Specialty Within the NSQIP Database. Spine. 2015;40(14):1122-1131. 31. Dasenbrock HH, Devine CA, Liu KX, et al. Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis. Cancer. 2016. 32. Lieber BA, Han J, Appelboom G, et al. Association of Steroid Use with Deep Venous Thrombosis and Pulmonary Embolism in Neurosurgical Patients: A National Database Analysis. World neurosurgery. 2016. 33. Kim BD, Smith TR, Lim S, Cybulski GR, Kim JY. Predictors of unplanned readmission in patients undergoing lumbar decompression: multi-institutional analysis of 7016 patients. Journal of neurosurgery Spine. 2014;20(6):606-616. 34. Dasenbrock HH, Liu KX, Devine CA, et al. Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurgical focus. 2015;39(6):E12. 35. Sellers MM, Merkow RP, Halverson A, et al. Validation of new readmission data in the American College of Surgeons National Surgical Quality Improvement Program. Journal of the American College of Surgeons. 2013;216(3):420-427.